Zurich Cantonal Bank
KRYS icon

Zurich Cantonal Bank’s Krystal Biotech KRYS Stock Holding History

Zurich Cantonal Bank’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
7,452
+2,313
+45% +$691K 0.01% 957
2026
Q1 		$1.33M Buy
5,139
+1,275
+33% +$339K ﹤0.01% 1267
2025
Q4 		$953K Hold
3,864
– – ﹤0.01% 1377
2025
Q3 		$682K Hold
3,864
– – ﹤0.01% 1538
2025
Q2 		$531K Sell
3,864
-1,878
-33% -$276K ﹤0.01% 1628
2025
Q1 		$1.04M Sell
5,742
-312
-5% -$52.5K ﹤0.01% 1140
2024
Q4 		$948K Buy
6,054
+1,440
+31% +$255K ﹤0.01% 1204
2024
Q3 		$840K Buy
4,614
+153
+3% +$29.5K ﹤0.01% 1219
2024
Q2 		$819K Buy
4,461
+169
+4% +$28.4K ﹤0.01% 1176
2024
Q1 		$764K Sell
4,292
-173
-4% -$24K ﹤0.01% 1212
2023
Q4 		$554K Sell
4,465
-22
-0.5% -$2.44K ﹤0.01% 1437
2023
Q3 		$520K Buy
4,487
+452
+11% +$55.1K ﹤0.01% 1376
2023
Q2 		$474K Buy
4,035
+1,298
+47% +$133K ﹤0.01% 1386
2023
Q1 		$219K Sell
2,737
-520
-16% -$40.9K ﹤0.01% 1809
2022
Q4 		$258K Sell
3,257
-832
-20% -$61.8K ﹤0.01% 1671
2022
Q3 		$285K Hold
4,089
– – ﹤0.01% 1543
2022
Q2 		$268K Sell
4,089
-36
-0.9% -$2.24K ﹤0.01% 1619
2022
Q1 		$274K Sell
4,125
-430
-9% -$26.8K ﹤0.01% 1701
2021
Q4 		$319K Buy
4,555
+3,603
+378% +$210K ﹤0.01% 1772
2021
Q3 		$50K Buy
952
+11
+1% +$651 ﹤0.01% 2613
2021
Q2 		$64K Buy
941
+39
+4% +$2.72K ﹤0.01% 2382
2021
Q1 		$69K Buy
+902
New +$65.6K ﹤0.01% 2299

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Zurich Cantonal Bank's KRYS Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Krystal Biotech (KRYS) stake by 45% in Q2 2026, buying an estimated $691K and bringing the position to 7,452 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #957.

Zurich Cantonal Bank first reported a position in KRYS in Q1 2021 and has held it in 22 quarters since. 422 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Zurich Cantonal Bank held 7,452 shares of Krystal Biotech worth $2.77M as of Q2 2026.
  • Zurich Cantonal Bank bought 2,313 Krystal Biotech shares in Q2 2026, an estimated $691K.
  • Krystal Biotech made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #957 holding.
  • Zurich Cantonal Bank first reported a position in Krystal Biotech in Q1 2021 and has held it in 22 quarters since.
  • 422 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.